Capillary Technologies India (CAPILLARY) Q4 23/24 earnings summary

Executive summary

• Consolidated revenue grew to ₹5,902.45 million in FY24 from ₹3,226.81 million in FY23, driven by international expansion and acquisitions.

• Net loss narrowed to ₹556.1 million in FY24 from ₹943.27 million in FY23, reflecting improved operational efficiency.

• Major acquisitions included Brierley entities and asset purchase from Tenerity, strengthening global presence.

Financial highlights

• Standalone revenue declined to ₹1,425.79 million in FY24 from ₹1,501.29 million in FY23.

• Standalone net loss reduced to ₹527.40 million from ₹905.56 million year-over-year.

• Consolidated EBITDA loss improved, with total expenses at ₹6,644.87 million versus ₹4,376.71 million last year.

• EPS (basic and diluted) improved to (₹10.55) from (₹17.53) year-over-year on a consolidated basis.

• Cash and cash equivalents increased to ₹1,806.68 million from ₹462.00 million year-over-year.

Outlook and guidance

• Management expects significant operational growth and improved cash flows, supporting long-term sustainability.

• No dividend proposed for FY24; focus remains on reinvestment and expansion.